Biotech and Pharmaceuticals

The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake | ReutersEli…
Read More...

Michael Siluk | UCG | Universal Images Group | Getty ImagesLosing weight with GLP-1 drugs is only half the battle.…
Read More...

AstraZeneca's failed late-stage trial for Wainua was never expected to have a major financial impact on the…
Read More...

Abivax's latest funding round allows the biotech to move toward a U.S. launch of its bowel disease drug without…
Read More...

Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed to meet its…
Read More...

In this photo illustration, Zyn nicotine cases are seen on a table on Jan. 29, 2024, in New York City.Michael M.…
Read More...

Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of…
Read More...

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel…
Read More...

Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a…
Read More...

Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news…
Read More...